The Gross Law Firm has issued a reminder to shareholders of Regencell Bioscience Holdings Limited about the upcoming June 23, 2026 deadline to seek lead plaintiff appointment in a securities class action. The class period runs from October 28, 2024 to October 31, 2025, and the complaint alleges that the company made materially false and misleading statements and failed to disclose vulnerability to market manipulation, exposing investors to significant financial risk and heightened regulatory scrutiny. Shareholders who purchased RGC shares during that period are encouraged to register, though participation as a lead plaintiff is not required for any potential recovery. The firm states there is no cost or obligation to participate.
Regencell Bioscience Holdings LtdSecurities class action lawsuit alleging false statements and failure to disclose market manipulation risks.